Tag: VPAG
Russell Abberley named Acting ABPI President as Susan Rienow becomes Pfizer CMO
As Acting ABPI President, he will focus on improving the UK’s international competitiveness in research, development, and the launch of innovative medicines
Russell Abberley, General...
£400 million VPAG investment programme launched to boost UK’s clinical trials
This new investment programme will lead to the creation of 18 new clinical trials hubs across UK to accelerate research
The UK government has announced...
DHSC publishes 2024 Voluntary Scheme agreement text
The new VPAG scheme will save the NHS £14 billion over five years in medicines costs Â
The Department of Health and Social Care (DHSC)...
Matthew Salzmann elected as new BGMA Vice Chair
He is committed to making the UK a global hub for off-patent medicine innovationÂ
The British Generic Manufacturers Association (BGMA) has elected Matthew Salzmann, UK...
New VPAG scheme to save NHS £14 billion
The level of annual allowed growth in sales of branded medicines will double from two per cent per year in 2024 to four per...
ABPI proposes ‘Voluntary Scheme for Pricing, Access and Growth’ to support NHS and economic growth
The Association of the British Pharmaceutical Industry (ABPI) has proposed a Voluntary Scheme for Pricing, Access and Growth (VPAG)Â that aims to deliver a sustainable...
